|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety comparison of liraglutide,glimepiride,and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (liraglutide effect and action in diabetes)-2 study显示文摘 | Nauck M Frid A Hermansen K | | Diabetes Care0，，： | 2 |
| 2 | Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization:contribution of progenitor cells显示文摘 | DAVIE N J CROSSNO J T FRID M G | 2004 | Am J Physiol Lung Cell Mol Physiol2004，286，4： | 1 |
| 3 | Hypoxia induces cell-specific changes in gene expression in vascular cells: implications for pulmonary hypertension显示文摘 | Stenmark KR Frid M NemenoffR etal | 1999 | Adv Exp Med Biol1999，474，： | 1 |
| 4 | Treatment of renal artery aneurysm with the multilayer stent显示文摘 | Henry M Polydorou A Frid N | | 0，，02： | 1 |
| 5 | Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD(liraglutide effect and action in diabetes)-2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | Diabetes Care2009，32，1： | 1 |
| 6 | Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with mefformin in type 2 diabetes: 2-year results from the LEAD-2 study显示文摘 | Nauck M Frid A Hermansen K | 2013 | Diabetes Obes Metab2013，150，： | 1 |
| 7 | Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage显示文摘 | FRID M G BRUNETTI J A BURKE D L | 2006 | Am J Pathol2006，168，2： | 1 |
| 8 | Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension 显示文摘 | Li M Riddle SR Frid MG | 2011 | J lmmunol2011，187，5： | 1 |
| 9 | Chronic fatigue syndrome:exercise and physical activity显示文摘 | Greenberg S Frid M | | 0，，04： | 1 |
| 10 | Chronic fatigue syndrome-exercise and physical activity显示文摘 | Greenberg S Frid M | 2006 | Human Kinetics2006，145，98： | 1 |
| 11 | Efficacy and safety comparison of liraglutide,glimepiride, and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (Liraglutide Effect and Action in Diabetes )-2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | J Diabetes Care2009，32，1： | 1 |
| 12 | Efficacy and safety comparison ofliraglutide, glimepiride, and placebo, all in combination with metformin, intype 2 diabetes: the LEAD -2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | Diabetes Care2009，32，： | 1 |
| 13 | Chronic fatigue syndrome exercise and physical activity显示文摘 | Greenberg S Frid M | 2006 | Human Kinetics2006，145，80： | 1 |
| 14 | Efficacy and Safety Comparison of Liraglutide,Glimepiride,and Placebo, All in Combination With Metformin,in type 2 Diabetes显示文摘 | Nauck M Frid A Hermansen K eta/ | 2009 | Diabetes Care2009，32，1： | 1 |
| 15 | Abnormalities in the reproductive health of flounder Platichthysflesus exposed to effluent from a sewage treatment works 显示文摘 | Lye C M Frid C L J Gill M E | 1997 | Marine Pollu- tion Bulletin1997，34，： | 1 |
| 16 | Efficacy and safety comparison of llraglutlde, gllmeplrlde, and placebo, all in combination with met- formin, in type 2 diabetes: The LEAD ( liraglutlde effect and action in- diabetes) -2 study 显示文摘 | Nauck M Frid A Hermansen K et aI | 2009 | Diabetes Care2009，32，1： | 1 |
| 17 | Role of the adventitia in pulmonary vascular remodeling 显示文摘 | Stenmark KR Davie N Frid M | 2006 | Physiology ( Bethesda )2006，21，2： | 1 |
| 18 | Hypoxia-induced pulmonary vascular remodeling:cellular and molecular mechanisms显示文摘 | Stenmark K R Fagan K A Frid M G | 2006 | Circ Res2006，99，7： | 1 |
| 19 | Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects 显示文摘 | Frid AH Nilsson M Hoist JJ | 2005 | Am J Clin Nutr2005，82，： | 1 |
| 20 | Efficacy and safety com- parison of liraglutide, glimepiride, and placebo, all in combina- tion with mefformin, in type 2 diabetes: the LEAD ( liraglutide effect and action in diabetes)-2 study显示文摘 | Nauek M Frid A Hermansen K | 2009 | Diabetes Care2009，32，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员